S.2036

Classifies xylazine as a Schedule III controlled dangerous substance in New Jersey.

New Jersey S2036 classifies xylazine as a Schedule III controlled dangerous substance, except when used by veterinarians. Xylazine, known as "tranq" or "zombie drug," is not approved for human use but is increasingly found in illegal street drugs. The bill sets penalties for illegal manufacture, distribution, dispensing, possession, use, or being under the influence of xylazine, with enhanced penalties for offenses near schools or public spaces. The Director of the Division of Consumer Affairs in the Department of Law and Public Safety is tasked with implementing the provisions of this act.